Cannabis, THC, CBD, and Fertility: the Evidence

Cannabis use has become common enough that many people trying to conceive use it regularly without thinking of it as a fertility factor. In states where it is legal, it is used for stress, sleep, pain, and recreation by a substantial fraction of adults in their reproductive years.

The Endocannabinoid System and Reproduction

The body has its own endocannabinoid system (ECS) that uses internally produced molecules like anandamide and 2-AG to regulate processes including ovulation, implantation, spermatogenesis, and early embryo development. Endocannabinoid receptors (CB1 and CB2) are present in the ovaries, uterus, testes, and sperm cells themselves.

The ECS is actively involved in regulating the timing of ovulation, endometrial receptivity for implantation, and sperm motility. When external cannabinoids like THC bind to these same receptors, they can disrupt the precisely timed endocannabinoid signaling that reproduction depends on.

THC and Female Fertility

THC has been shown to suppress GnRH secretion from the hypothalamus, which can reduce LH and FSH levels. In regular users, this can manifest as longer or irregular menstrual cycles and anovulatory cycles. A prospective study in Human Reproduction found that women who used cannabis had a modest but statistically significant increase in time to pregnancy compared to non-users.

At the uterine level, THC alters endocannabinoid signaling at the implantation site. Animal studies demonstrate that elevated cannabinoid receptor activation during the implantation window disrupts embryo-uterine communication, reducing implantation rates.

THC and Male Fertility

The evidence for male reproductive effects is stronger than for female effects. Multiple studies, including a Fertility and Sterility meta-analysis, found associations between cannabis use and reduced sperm concentration, count, and morphology.

THC also affects sperm function directly. In vitro studies show impaired acrosome reaction and reduced motility. These functional impairments could reduce fertilization rates even when counts remain normal.

One counterintuitive Harvard cohort finding showed slightly higher concentrations in ever-users, but this is likely confounded by the healthy-user effect and does not apply to current regular use.

CBD: a Different Compound, Less Data

CBD does not bind directly to CB1 receptors the way THC does. It modulates the system indirectly by inhibiting the enzyme that breaks down anandamide. The research on CBD and fertility specifically is sparse. People often assume CBD is reproductively benign because it is non-psychoactive, but non-psychoactive and non-bioactive are not the same thing.

An additional concern: independent testing has repeatedly found that commercial CBD products contain undisclosed THC, sometimes at measurable levels.

Smoking as a Separate Layer of Harm

Smoking cannabis introduces combustion products including carbon monoxide, tar, and polycyclic aromatic hydrocarbons. These have their own documented negative effects on fertility independent of THC. Carbon monoxide reduces oxygen delivery to the ovaries and testes. PAHs are known reproductive toxicants.

Edibles avoid combustion exposure but deliver THC to the same endocannabinoid receptors. Vaping reduces but does not eliminate inhalation concerns.

The Abstinence Timeline

For women, stopping at least one full menstrual cycle before actively trying gives the current follicle cohort a THC-free maturation window. Three months is more conservative and aligns with the roughly 90-day final oocyte maturation period.

For men, spermatogenesis takes approximately 74 days. Stopping at least three months before TTC allows a complete sperm production cycle without THC exposure. Since THC is lipophilic and stored in fat tissue, heavier users may take longer to fully clear.